3Korppi M,Heiskanen-Kosma T,Kleemola M.Incidence of community-acquired pneumonia in children caused by Mycoplasna pneumoniae:serological results of a prospective,population-based study in primary health care.Respirology,2004,9:109-114. 被引量：1
4Principi N,Esposito S.Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients.Curr Opin Infect Dis,2002,15:295-300. 被引量：1
6Bebear CM,Pereyre S.Mechanisms of drug resistance in Mycoplasma pneumoniae Curr Drug Targets Infect Disord,2005,5:263-271. 被引量：1
7Matsuoka M,Narita M,Olazaki N,et al.Charscterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.Antimicrob Agents Chemother,2004,48:4624-4630. 被引量：1
8Lee KY,lee HS,Hong JH,et al.Role of prednisone treatment in severe Mycoplasma pneumoniae in children.Pediatr Pulmonol,2006,41:263-268. 被引量：1
9Okazaki N,Narita M,Yamada S,et al.Characteristics of macrolide-resistant Mycoplasma pneumoniae strnins isolated from patients and induced with erythhromycin in vitro.Microbiol Immunol,2001,45:617-620. 被引量：1
1Chastel C.Edmond Nocard (1850-1903) and the centenary of the dis- covery of the first mycoplasma (1898)[J].Hist Sci Med. 1999 Oct-Dee; 33(4):311-315. 被引量：1
2Jeong YC, Yeo MS, Kim JH, et al. Mycoplasma pneumoniae Infection Affects the Serum Levels of Vascular Endothelial Growth Factor and In- terleukin-5 in Atopic Children[J].Allergy Asthma Immunol Res,2012, 4 (2) : 92-97. 被引量：1
